A New Dawn for Alzheimer’s: Phase I Trial Targets Senescent Cells Safely

Wake Forest University researchers are exploring cellular senescence's role in Alzheimer's disease. By using a repurposed cancer drug and an antioxidant, initial tests show potential in targeting these problematic cells, but larger studies are needed for confirmation.